Insulin signaling in skeletal muscle during inflammation and/or immobilisation
Open Access
- 27 March 2023
- journal article
- research article
- Published by Springer Nature in Intensive Care Medicine Experimental
- Vol. 11 (1) , 1-13
Abstract
Background: The decline in the downstream signal transduction pathway of anabolic hormone, insulin, could play a key role in the muscle atrophy and insulin resistance observed in patients with intensive care unit acquired weakness (ICUAW). This study investigated the impact of immobilisation via surgical knee and ankle fixation and inflammation via Corynebacterium parvum injection, alone and in combination, as risk factors for altering insulin transduction and, therefore, their role in ICUAW. Results: Muscle weight was significantly decreased due to immobilisation [estimated effect size (95% CI) − 0.10 g (− 0.12 to − 0.08); p < 0.001] or inflammation [estimated effect size (95% CI) − 0.11 g (− 0.13 to − 0.09); p < 0.001] with an additive effect of both combined (p = 0.024). pAkt was only detectable after insulin stimulation [estimated effect size (95% CI) 85.1-fold (76.2 to 94.0); p < 0.001] irrespective of the group and phosphorylation was not impaired by the different perturbations. Nevertheless, the phosphorylation of GSK3 observed in the control group after insulin stimulation was decreased in the immobilisation [estimated effect size (95% CI) − 40.2 (− 45.6 to − 34.8)] and inflammation [estimated effect size (95% CI) − 55.0 (− 60.4 to − 49.5)] groups. The expression of phosphorylated GS (pGS) was decreased after insulin stimulation in the control group and significantly increased in the immobilisation [estimated effect size (95% CI) 70.6-fold (58.8 to 82.4)] and inflammation [estimated effect size (95% CI) 96.7 (85.0 to 108.5)] groups. Conclusions: Both immobilisation and inflammation significantly induce insulin resistance, i.e., impair the insulin signaling pathway downstream of Akt causing insufficient GSK phosphorylation and, therefore, its activation which caused increased glycogen synthase phosphorylation, which could contribute to muscle atrophy of immobilisation and inflammation.Keywords
Funding Information
- Berlin Institute of Health (Junior Clinician Scientist)
- Technische Universität München
This publication has 41 references indexed in Scilit:
- Inducible nitric oxide synthase deficiency ameliorates skeletal muscle insulin resistance but does not alter unexpected lower blood glucose levels after burn injury in C57BL/6 miceMetabolism, 2012
- Novel events in the molecular regulation of muscle mass in critically ill patientsThe Journal of Physiology, 2011
- Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activationThe FASEB Journal, 2009
- Distinct effects of subcellular glycogen localization on tetanic relaxation time and endurance in mechanically skinned rat skeletal muscle fibresThe Journal of Physiology, 2009
- AMPK Phosphorylation of Raptor Mediates a Metabolic CheckpointMolecular Cell, 2008
- Systemic inflammatory response syndrome increases immobility-induced neuromuscular weakness*Critical Care Medicine, 2008
- The Rab GTPase-Activating Protein AS160 Integrates Akt, Protein Kinase C, and AMP-Activated Protein Kinase Signals Regulating GLUT4 TrafficDiabetes, 2007
- GSK-3β inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat*Critical Care Medicine, 2005
- Burn injury impairs insulin-stimulated Akt/PKB activation in skeletal muscleAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase‐3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulinFEBS Letters, 1998